P&T Committees Will Be New Focus For Pharma Prosecutors

Pharmacy & therapeutic committees will be a focus of scrutiny for federal prosecutors once the Medicare Part D benefit takes effect in 2006, Boston U.S. Attorney's Office White Collar Crime Section Chief Michael Loucks said Jan. 31 during CBI's Pharmaceutical Marketing Compliance Congress in Washington, D.C